NCT01927159View on ClinicalTrials.gov

Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Pulmonary Tuberculosis
Interventions
BIOLOGICAL

ID93 + GLA-SE

OTHER

Placebo

Trial Locations (1)

6850

SATVI, Worcester

Sponsors

Collaborators (1)

Aeras
All Listed Sponsors
collaborator

Aeras

OTHER

collaborator

South African Tuberculosis Vaccine Initiative

OTHER

lead

Access to Advanced Health Institute (AAHI)

OTHER

NCT01927159 - Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter